» Articles » PMID: 32998923

Nature of Adverse Events with Opioids in Hospitalised Patients: a Post-hoc Analysis of Three Patient Record Review Studies

Overview
Journal BMJ Open
Specialty General Medicine
Date 2020 Oct 1
PMID 32998923
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Opioids are increasingly prescribed and frequently involved in adverse drug events (ADEs). The underlying nature of opioid-related ADEs (ORADEs) is however understudied. This hampers our understanding of risks related to opioid use during hospitalisation and when designing interventions. Therefore, we provided a description of the nature of ORADEs.

Design: A post-hoc analysis of data collected during three retrospective patient record review studies (in 2008, 2011/2012 and 2015/2016).

Setting: The three record review studies were conducted in 32 Dutch hospitals.

Participants: A total of 10 917 patient records were assessed by trained nurses and physicians.

Outcome Measures: Per identified ORADE, we described preventability, type of medication error, attributable factors and type of opioids involved. Moreover, the characteristics of preventable and non-preventable ORADEs were compared to identify risk factors.

Results: Out of 10 917 patient records, 357 ADEs were identified, of which 28 (8%) involved opioids. Eleven ORADEs were assessed as preventable. Of these, 10 were caused by dosing errors and 4 probably contributed to patients' death. Attributable factors identified were mainly on patient and organisational levels. Morphine and oxycodone were the most frequently involved opioids. The risk for ORADEs was higher in elderly patients.

Conclusions: Only 8% of ADEs identified in our sample were related to opioids. Although the frequency is low, the risk of serious consequences is high. We recommend to use our findings to increase awareness among physicians and nurses. Future interventions should focus on safe dosing of opioids when prescribing and administering, especially in elderly patients.

Citing Articles

Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?.

Tarantino G, Cataldi M, Citro V Front Microbiol. 2024; 15:1319897.

PMID: 39687876 PMC: 11646994. DOI: 10.3389/fmicb.2024.1319897.


Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic Review.

Gustafsson M, Silva V, Valeiro C, Joaquim J, van Hunsel F, Matos C Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204114 PMC: 11357286. DOI: 10.3390/ph17081009.

References
1.
de Vet H, Mokkink L, Terwee C, Hoekstra O, Knol D . Clinicians are right not to like Cohen's κ. BMJ. 2013; 346:f2125. DOI: 10.1136/bmj.f2125. View

2.
Brennan T, Leape L, Laird N, Hebert L, Localio A, Lawthers A . Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991; 324(6):370-6. DOI: 10.1056/NEJM199102073240604. View

3.
Huang A, Mallet L . Prescribing opioids in older people. Maturitas. 2012; 74(2):123-9. DOI: 10.1016/j.maturitas.2012.11.002. View

4.
Oderda G, Gan T, Johnson B, Robinson S . Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother. 2013; 27(1):62-70. DOI: 10.3109/15360288.2012.751956. View

5.
Baines R, Langelaan M, de Bruijne M, Asscheman H, Spreeuwenberg P, van de Steeg L . Changes in adverse event rates in hospitals over time: a longitudinal retrospective patient record review study. BMJ Qual Saf. 2013; 22(4):290-8. DOI: 10.1136/bmjqs-2012-001126. View